Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
5.23
-0.32 (-5.77%)
May 13, 2025, 4:00 PM - Market closed
Enanta Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2015 - 2019 |
| Cash & Equivalents | 60.21 | 37.23 | 85.39 | 43.99 | 57.21 | 87.13 | Upgrade
|
| Short-Term Investments | 133.16 | 210.95 | 284.52 | 205.24 | 186.8 | 299.52 | Upgrade
|
| Cash & Short-Term Investments | 193.38 | 248.19 | 369.91 | 249.23 | 244 | 386.65 | Upgrade
|
| Cash Growth | -35.61% | -32.91% | 48.42% | 2.14% | -36.89% | 15.34% | Upgrade
|
| Accounts Receivable | 6.79 | 6.65 | 8.61 | 20.32 | 23.58 | 23.49 | Upgrade
|
| Other Receivables | 33.84 | 32 | 31 | 28.72 | 37.26 | 13.04 | Upgrade
|
| Receivables | 40.63 | 38.65 | 39.62 | 49.04 | 60.83 | 36.53 | Upgrade
|
| Prepaid Expenses | 8.86 | 12.41 | 13.26 | 13.45 | 14.19 | 13.66 | Upgrade
|
| Restricted Cash | - | 0.61 | - | - | - | - | Upgrade
|
| Total Current Assets | 242.86 | 299.85 | 422.79 | 311.71 | 319.02 | 436.84 | Upgrade
|
| Property, Plant & Equipment | 76.68 | 73.35 | 34.71 | 29.75 | 10.65 | 15.62 | Upgrade
|
| Long-Term Investments | - | - | - | 29.29 | 108.42 | 32.63 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | - | - | 0.35 | Upgrade
|
| Other Long-Term Assets | 3.46 | 3.45 | 4.77 | 4.66 | 0.7 | 0.7 | Upgrade
|
| Total Assets | 322.99 | 376.65 | 462.28 | 375.41 | 438.79 | 486.13 | Upgrade
|
| Accounts Payable | 4.76 | 8 | 4.1 | 6 | 9.54 | 5.74 | Upgrade
|
| Accrued Expenses | 8.31 | 13.55 | 18.34 | 20.94 | 22.43 | 14.16 | Upgrade
|
| Current Portion of Long-Term Debt | 30.68 | 34.46 | 35.08 | - | - | - | Upgrade
|
| Current Portion of Leases | 2.2 | 1.52 | 5.28 | 2.89 | 4.2 | 4.26 | Upgrade
|
| Total Current Liabilities | 45.95 | 57.54 | 62.79 | 29.83 | 36.17 | 24.16 | Upgrade
|
| Long-Term Debt | 126.73 | 136.13 | 160.85 | 1.42 | 1.51 | 1.48 | Upgrade
|
| Long-Term Leases | 56.54 | 53.94 | 21.24 | 22.37 | 1.13 | 3.84 | Upgrade
|
| Other Long-Term Liabilities | 0.24 | 0.23 | 0.66 | 0.45 | 0.56 | 1.08 | Upgrade
|
| Total Liabilities | 229.46 | 247.84 | 245.54 | 54.08 | 39.36 | 30.55 | Upgrade
|
| Common Stock | 93.54 | 0.21 | 0.21 | 0.21 | 0.2 | 0.2 | Upgrade
|
| Additional Paid-In Capital | - | 451.34 | 424.69 | 398.03 | 351.03 | 326.96 | Upgrade
|
| Retained Earnings | - | -323.04 | -207 | -73.18 | 48.58 | 127.57 | Upgrade
|
| Comprehensive Income & Other | - | 0.3 | -1.17 | -3.72 | -0.38 | 0.84 | Upgrade
|
| Shareholders' Equity | 93.54 | 128.81 | 216.74 | 321.33 | 399.43 | 455.58 | Upgrade
|
| Total Liabilities & Equity | 322.99 | 376.65 | 462.28 | 375.41 | 438.79 | 486.13 | Upgrade
|
| Total Debt | 216.14 | 226.06 | 222.44 | 26.69 | 6.84 | 9.58 | Upgrade
|
| Net Cash (Debt) | -22.77 | 22.13 | 147.47 | 251.83 | 345.58 | 409.71 | Upgrade
|
| Net Cash Growth | - | -85.00% | -41.44% | -27.13% | -15.65% | 2.86% | Upgrade
|
| Net Cash Per Share | -1.07 | 1.05 | 7.03 | 12.22 | 17.13 | 20.55 | Upgrade
|
| Filing Date Shares Outstanding | 21.36 | 21.19 | 21.06 | 20.8 | 20.32 | 20.08 | Upgrade
|
| Total Common Shares Outstanding | 21.36 | 21.19 | 21.06 | 20.79 | 20.24 | 20.08 | Upgrade
|
| Working Capital | 196.91 | 242.32 | 360 | 281.89 | 282.85 | 412.68 | Upgrade
|
| Book Value Per Share | 4.38 | 6.08 | 10.29 | 15.46 | 19.74 | 22.69 | Upgrade
|
| Tangible Book Value | 93.54 | 128.81 | 216.74 | 321.33 | 399.43 | 455.58 | Upgrade
|
| Tangible Book Value Per Share | 4.38 | 6.08 | 10.29 | 15.46 | 19.74 | 22.69 | Upgrade
|
| Machinery | - | 19.92 | 19.14 | 16.79 | 16.32 | 15.82 | Upgrade
|
| Construction In Progress | - | 22.75 | 1.27 | 2.56 | 0.02 | - | Upgrade
|
| Leasehold Improvements | - | 13.98 | 13.8 | 7.28 | 7.14 | 7.09 | Upgrade
|
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.